
Protagenic Therapeutics, Inc. (NASDAQ: PTIX), relating to the proposed merger with Phytanix Bio Inc. Under the terms of the agreement, stockholders of Protagenic Therapeutics will own approximately 35% of the combined company.
Protagenic Therapeutics, Inc. (NASDAQ: PTIX), relating to the proposed merger with Phytanix Bio Inc. Under the terms of the agreement, stockholders of Protagenic Therapeutics will own approximately 35% of the combined company.